Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
taVNS for Chronic Constipation
NCT05723731Terminated
- Sponsor
- Air Force Medical University
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Air Force Medical University. Primary endpoint: Responder rate at 4 weeks. Started Jan 2023; status: terminated.
Beyond the preview
Go deeper on NCT05723731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723731.